Other molecules that have been shown to be potent inhibitors of TGF-β in GBM are cholesterol-lowering statins, which could be used as adjunct therapy in GBM treatment, as simvastatin reduced invasion at the tumor margin and prolonged mouse survival [151]. The gene discussed is TGFB1; the disease is neoplasm.